DRIO vs GILD · rev $10.8M vs P/E 18, rev $7.80B
DarioHealth Corp (DRIO) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
DarioHealth Corp (DRIO) is a health information services company listed on NASDAQ.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Latest reported DRIO revenue for 2026-06-30 was $10.8M. Net income was -$16.2M. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. DRIO currently screens at market cap $52.1M.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
DRIO currently screens at market cap $52.1M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the DRIO and GILD stock pages for the full models.
Not investment advice.